Rybelsus 7 mg uses to treat the following:

• Type 2 diabetes mellitus

• Obesity or overweight.

Rybelsus 7mg tablet, a GLP-1 receptor agonist, exerts its therapeutic effects by mimicking the action of the naturally occurring hormone GLP-1. In diabetes management, this medication enhances insulin secretion, inhibits glucagon release, slows gastric emptying, and decreases hepatic glucose production. This medication effect leads to improved glycemic control and reduced HbA1c levels. Additionally, this medication promotes weight loss through increased satiety, decreased food intake, and modulation of gastric function. It has also demonstrated cardiovascular benefits, including a potential reduction in major cardiovascular events.

Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Rybelsus 7mg tablet, reducing effectiveness by causing undesirable side effects. 

Rybelsus 7 mg storage instructions are:

• Stored in a refrigerator from 2°C to 8°C.

• Keep away from moisture, heat, and light.

• It should not be frozen.

• Keep away from children and pets.

Rybelsus 7mg tablet is typically administered as a subcutaneous injection. The injection can be given in the abdomen, thigh, or upper arm. These medication pens come with clear instructions on how to load the needle, dial the dose, and administer the injection. After injecting, dispose of the needle safely in a sharps container. Regular monitoring and follow-up with your healthcare provider are important to assess your progress and make any necessary adjustments to your treatment plan.

Rybelsus 7 mg side effects, like all medications, although not everyone will experience them. 

Serious

• Allergic reactions

• Pancreatitis (abdominal pain, nausea, vomiting)

• Hypoglycemia (low blood sugar)

• Kidney problems (changes in urination, swelling in the ankles or feet)

• Thyroid C-cell tumors

Common

• Nausea

• Vomiting

• Diarrhea

• Constipation

• Abdominal pain

• Decreased appetite

• Headache

• Fatigue

• Injection site reactions (e.g., redness, pain, itching)

1. Share Medical History: Inform your healthcare provider if you have or have had pancreatitis, thyroid disorders, kidney or liver issues, or gallbladder disease before starting Rybelsus 7mg tablet.

2. Monitor Blood Sugar Levels: Check your blood glucose regularly to prevent hypoglycemia, especially if you are using other antidiabetic medications.

3. Follow Dosage and Injection Guidelines: Stick to the prescribed dose and schedule, and rotate injection sites to reduce the chance of skin reactions or irritation.

4. Consult and Report Symptoms: Pregnant or breastfeeding women should consult their doctor, and any unusual symptoms, such as abdominal pain or skin reactions, should be reported immediately while maintaining regular follow-up visits.

1. Novo Nordisk Inc, FDA Food and Drug Safety Administration [September 20, 2019] [Accessed date 18th August 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/213051s000lbl.pdf

2. Novo Nordisk Limited, EMC,  [25 Jan 2023], [Accessed date 18th August 2023] Electronic Medicines Compendium (EMC), [Revised on 25th Jan 2023] [Accessed on 18 August 2023] https://www.medicines.org.uk/emc/product/11507/pil